WHO ICTRP trial
Greater occipital nerve block for a sooner en and better treatment of cluster…
EUCTR2018-002224-17-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2018-002224-17-NL |
|---|---|
| Public title | Greater occipital nerve block for a sooner en and better treatment of cluster headache |
| Scientific title | GON-injection for a sooner and better treatment of cluster headache: a double-blind randomized controlled trial - CHIANTI |
| Primary sponsor | Leids Universitair Medisch Centrum |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | Episodic cluster headache;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] |
| Interventions | Trade Name: Depo-Medrol 40 mg/ml, suspensie voor injectie Product Name: Methylprednisolonacetaat Pharmaceutical Form: Injection Pharmaceutical form of the placebo: Solution for injection Route of administration of the placebo: Infiltration |
| Registration date | Dec 20, 2018 |
| Target size | 80 |
| Secondary IDs | 201805GON |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: